About Pillcheck

Pillcheck is a genomics-guided medication management service that helps individuals feel better sooner on the right medication. Our mission is to make guidelines-based personalized medicine accessible and affordable.

Our proprietary platform is preferred by leading Canadian insurers and employers because it provides secure data management and tracks the progress and impact of personalized medicine.

Pillcheck follows best practices around genetic non-discrimination legislation and health data privacy laws globally. It also includes a proven pharmacogenomics implementation package for healthcare providers. Healthcare providers are two times more efficient in identifying and correcting Drug Therapy Problems with Pillcheck. Our analysis reflects the unique health needs of individuals with ancestry from different parts of the world.

Pillcheck is at the forefront of helping organizations to rethink how they invest in mental well-being. Based on demonstrated results from an independent Randomized Controlled Trial.


We work at the frontier of applying genetic technology, medication management and AI to help improve people’s health and optimize health expenditures incurred by individuals and health plan sponsors.

Pillcheck service delivery is supported by a network of independent clinical pharmacists licensed to practice in Canada.

Veronika Litinski – CEO

Veronika is a company builder, digital health technology innovator and financier. Her expertise in launching innovative medical sector products, building teams and developing winning commercial alliances underpin the growth trajectory at Pillcheck. Veronika piloted the launch and development of Cogniciti (cogniciti.com). Cogniciti’s digital health product suite helps millions of adults with memory concerns get earlier assessment, diagnosis and treatment. She was Practice Lead for Health during the initial growth years at MaRS Discovery District (marsdd.com). Veronika managed international Venture Finance Partnerships at GATX Capital in San Francisco (NYSE: GMT) and worked in cancer research at Lawrence Livermore Laboratory in Berkeley.

Ruslan Dorfman, PhD, MBA – Founder, CSO

Ruslan is a trailblazer in personalized medicine, a molecular geneticist and a technology builder. Inspired by direct interactions with Cystic Fibrosis families from all over the world, Ruslan co-founded Pillcheck (formerly GeneYouIn Inc) to facilitate access to advanced genetics for the general public. He managed large-scale R&D programs at Sick Kids Hospital, Toronto and advised Bridgepoint and Mt. Sinai hospitals on implementing personalized medicine programs. Ruslan has published sixty peer-reviewed papers on the genetics of Cystic Fibrosis and Pain.

Boyko Kabakchiev, PhD – CTO

Boyko has evolved his career in software platform development from a background in mathematics and biology. He holds a doctoral degree in human genetics and bioinformatics. At Pillcheck, Boyko ensures regulatory framework compliance and hazard mitigation by design and develops smart business analytics using machine learning. He is dedicated to implementing a continuous rapid product improvement program to enable accurately personalized medicine. His goal is to deliver the best science to facilitate the best health outcomes. For years his work has focused on applying cutting-edge analytical algorithms to understand the genetic causes of complex disorders of the immune system. Boyko has published 22 peer-reviewed papers on how analytical methods improve diagnosis and prognosis for patients.

Lou Carsley – Chief Customer Officer

Lou’s background spans consumer marketing, business development, and channel management in the corporate wellness and consumer product areas. As Chief Customer Officer of Pillcheck, he focuses on the development and growth of the Pillcheck platform, including marketing strategy, customer experience, and communications. Lou was Chief Marketing and Operating Officer of Newtopia, a company that delivers personalized wellness programs to at-risk employees and prior, he was GM of Nutrisystem Canada.

Liz Garman, MBA – Customer Solutions Manager

Liz brings organizational and project management skills to the Pillcheck team. She is responsible for the delivery of quality solutions in customer experience, process design and business operations. Before joining Pillcheck, Liz spent more than nine years in planning & logistics projects and operations at Intel. She is excited to be part of a team developing and delivering quality personalized medicine for individuals and the healthcare space.

Gil Mcgowan – Business & Sales Strategy

Gil is an experienced Sales and Marketing executive with a successful history working in Group Benefits, Group Retirement, Mutual Funds and the Insurance industry. He consults on Business Development Solutions and Strategic Planning.

Gouri Mukerjee, PhD – Science Advisor

Gouri is a genetic testing expert with vast experience in the field of molecular genetics. She has worked on both basic and applied projects in Tokyo, investigating enzymes & pathways that metabolize xenobiotics, and at Sick Kids Hospital in Toronto. A skilled molecular biologist, she is passionate about utilizing the latest technologies to uncover the biological code that makes us who we are. A firm believer in personalized medicine, she envisions our unique genetic constitutions being routinely used to customize lifestyle advice and medical therapies.


Micheline Piquette-Miller, PhD — Professor, Leslie Dan Faculty of Pharmacy, University of Toronto

Micheline Piquette-Miller is a Professor in Pharmacokinetics at the Leslie Dan Faculty of Pharmacy at the University of Toronto and an Associate Editor of Clinical Pharmacology and Therapeutics. She received a Ph.D. in Pharmacokinetics (U of Alberta) and completed a fellowship in Molecular Pharmacology (UCSF). Her research focuses on understanding the molecular mechanisms responsible for patient variability in drug response and has received numerous prestigious national and international research awards. Micheline has taught fundamental concepts and clinical translation of pharmacokinetics, pharmacogenetics and personalized medicine at the University of Toronto for over 15 years. She served as Chair of the Pharmacogenetics and Molecular Pharmacology Section for the American Society of Clinical Pharmacology & Therapeutics from 1999-2005 and is past president of the Canadian Society of Clinical Pharmacology.

John Papastergiou – Community Pharmacy Owner, Adjunct Assistant Professor at The School Of Pharmacy, University of Waterloo, and The Leslie Dan Faculty of Pharmacy at University of Toronto

John Papastergiou is the owner and operator of three Shoppers Drug Mart locations in downtown Toronto and is an adjunct assistant professor at the School of Pharmacy, University of Waterloo, as well as at the Leslie Dan Faculty of Pharmacy, University of Toronto.  In 2014 he was appointed to the Ontario Pharmacist Research Collaboration (OPEN), and in 2017 collaborated with Pillcheck on a published study involving pharmacogenetics in community pharmacy using Pillcheck. In addition, he has implemented one of the first frontline community pharmacist-directed pharmacogenomics clinics in Canada. His work in this area won first prize at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Buenos Aires, Argentina.

In 2014, he received the OPA Mentorship Award and was named CPhA Canadian Pharmacist of the Year.  In 2016, he received the OPA Voice of the Profession Award and the Pharmacy Practice Commitment to Care Award for Overall Patient Care.  In 2019, John was named by the International Forum on Advancement in Healthcare as one of the top 100 healthcare leaders globally.  He was also presented with the OPA Award for Excellence in Research and Academia.

Scott Kahn, PhD — Recently retired CIO of Illumina

Scott Kahn is the Chief Information and Privacy Officer at LunaPBC, a private investor-owned company founded in November 2017. The public benefit corporation is chartered to drive societal value through the aggregation and organization of genomic and health data at a scale and diversity rich enough to solve today’s greatest health challenges. LunaPBC founded LunaDNA, the world’s first community-owned health database that offers shares of ownership to health data contributors. As an expert in global data privacy regulation compliance, Scott leads the integration of data privacy and security provisions that comply with GDPR and HIPAA at LunaDNA. Scott is also on the Board of Directors at Blue Circle Health and Rady Children’s Institute for Genomic Medicine and was the former Chief Information Officer and Vice President Commercial, Enterprise Informatics at Illumina.

Mark Foerster — Recently retired Vice President, Group Operations & Claims at Munich Re Canada (Life)

Mark Foerster has an MBA/HBA from the University of Western Ontario, Richard Ivey School of Business. He currently holds an executive position at Munich Re, one of the world’s leading reinsurance companies with approximately 45,000 employees in over 50 locations around the globe. Mark has served on numerous not-for-profit boards and is currently a director on the Children’s Aid Society of Toronto.

Skip to content